GNOM ETF holdings (NASDAQ) - Page 2 | MetaTrader

Abrir gráfico completo Full chart

Visão geral Todos os ativos Mapa de calor

Principais ativos Market Value Shares Weight %

A

AZN ASTRAZENECA PLC 1.2 M 5 706.0 2.3%

BEAM Beam Therapeutics Inc 1.2 M 40.6 K 2.2%

TXG 10X Genomics Inc 1.1 M 49.1 K 2.2%

LEGN Legend Biotech Corp 1.1 M 59.1 K 2.1%

RARE Ultragenyx Pharmaceutical Inc 930.4 K 39.8 K 1.8%

WGS GeneDx Holdings Corp 898.3 K 11.3 K 1.7%

WVE WAVE Life Sciences Ltd 786.3 K 56.4 K 1.5%

Genscript Biotech Corp 761.6 K 498.9 K 1.5%

SRPT SAREPTA THERAPEUTICS, INC. 686.8 K 41.0 K 1.3%

NTLA INTELLIA THERAPEUTICS, INC. 621.1 K 45.1 K 1.2%

CDNA CAREDX, INC. 418.5 K 22.3 K 0.8%

QURE Uniqure NV 378.9 K 24.2 K 0.7%

VIR Vir Biotechnology Inc 364.9 K 40.1 K 0.7%

PSNL Personalis Inc 213.5 K 23.6 K 0.4%

PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 200.8 K 119.5 K 0.4%

A AGILENT TECHNOLOGIES, INC. 200.6 K 1 653.0 0.4%

RCKT ROCKET PHARMACEUTICALS, INC. 188.2 K 37.6 K 0.4%

PRME Prime Medicine Inc 187.9 K 40.7 K 0.4%

RGNX Regenxbio Inc 185.2 K 20.5 K 0.4%

MYGN MYRIAD GENETICS, INC. 180.9 K 39.2 K 0.3%

1
2
3

Notícias

First Quarter Earnings: Sharpening Sector Divergence

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

The Next Big Theme: May 2026

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Medical Technology Stocks: Innovation Endures As Valuations Reset

The Next Big Theme: April 2026

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

Concerns Shift From Obsolescence To Oil